{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T20:52:26Z","timestamp":1775595146025,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00380-019-01377-2","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T09:02:19Z","timestamp":1552554139000},"page":"1381-1388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Edoxaban suppresses the progression of atrial fibrosis and atrial fibrillation in a canine congestive heart failure model"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8036-3378","authenticated-orcid":false,"given":"Yasushi","family":"Tsujino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","volume":"124","author":"YK Iwasaki","year":"2011","unstructured":"Iwasaki YK, Nishida K, Kato T, Nattel S (2011) Atrial fibrillation pathophysiology: implications for management. Circulation 124:2264\u20132274","journal-title":"Circulation"},{"key":"1377_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.114.303466","volume":"114","author":"K Nishida","year":"2014","unstructured":"Nishida K, Nattel S (2014) Atrial fibrillation compendium: historical context and detailed translational perspective on an important clinical problem. Circ Res 114:1447\u20131452","journal-title":"Circ Res"},{"key":"1377_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel S, Burestein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 1:62\u201373","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1377_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCRESAHA.108.183400","volume":"105","author":"B Burstein","year":"2009","unstructured":"Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh YH, Nattel S (2009) Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ Res 105:1213\u20131222","journal-title":"Circ Res"},{"key":"1377_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/CIRCULATIONAHA.110.972778","volume":"123","author":"K Nishida","year":"2011","unstructured":"Nishida K, Qi XY, Wakili R, Comtois P, Chaetier D, Harada M, IwasakiYK Romeo P, Maguy A, Dobrev D, Michael G, Talajic M, Nattel S (2011) Mechanisms of atrial tachyarrhythmia associated with coronary artery occlusion in a chronic canine model. Circulation 123:137\u2013146","journal-title":"Circulation"},{"key":"1377_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","volume":"51","author":"B Burstein","year":"2008","unstructured":"Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802\u2013809","journal-title":"J Am Coll Cardiol"},{"key":"1377_CR7","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMra1011670","volume":"364","author":"J Borisoff","year":"2011","unstructured":"Borisoff J, Spronk HM, ten Cate H (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364:1746\u20131760","journal-title":"N Engl J Med"},{"key":"1377_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/cvr\/cvt343","volume":"101","author":"HM Spronk","year":"2014","unstructured":"Spronk HM, de Jong AM, Crijns HJ, Schotten U, Van Gelder IC, Ten Cate H (2014) Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants. Cardiovasc Res 101:344\u2013351","journal-title":"Cardiovasc Res"},{"key":"1377_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejphar.2013.09.006","volume":"718","author":"A Bukowska","year":"2013","unstructured":"Bukowska A, Zacharias I, Weinert S, Skopp K, Hartmann C, Huth C, Goette A (2013) Coagulation factor Xa induces an inflammatory signaling by activation of protease-activated receptors in human atrial tissue. Eur J Pharmacol 718:114\u2013123","journal-title":"Eur J Pharmacol"},{"key":"1377_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.molmed.2008.08.001","volume":"14","author":"K Borensztajn","year":"2008","unstructured":"Borensztajn K, Peppelenbosch MP, Spek CA (2008) Factor Xa: at the crossroads between coagulation and signaling in physiology and disease. Trends Mol Med 14:429\u2013440","journal-title":"Trends Mol Med"},{"key":"1377_CR11","doi-asserted-by":"publisher","first-page":"e81733","DOI":"10.1371\/journal.pone.0081733","volume":"8","author":"S Antoniak","year":"2013","unstructured":"Antoniak S, Sparkenbaugh EM, Tencati M, Rojas M, Mackman N, Pawlinski R (2013) Protease activated receptor-2 contributes to heart failure. PLoS ONE 8:e81733","journal-title":"PLoS ONE"},{"key":"1377_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2353\/ajpath.2008.070347","volume":"172","author":"K Borenstajin","year":"2008","unstructured":"Borenstajin K, Stiekema J, Nijmeijer S, Reitsma PH, Peppelenbosch MP, Spek CA (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 172:309\u2013320","journal-title":"Am J Pathol"},{"key":"1377_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jjcc.2017.08.007","volume":"71","author":"H Kondo","year":"2018","unstructured":"Kondo H, Abe I, Fukui A, Saito S, Miyoshi M, Aoki K, Shinohara T, Teshima Y, Yufu K, Takahashi N (2018) Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation. J Cardiol 71:310\u2013319","journal-title":"J Cardiol"},{"key":"1377_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.thromres.2018.05.015","volume":"167","author":"MF Bode","year":"2018","unstructured":"Bode MF, Auriemma AC, Grove SP, Hisada Y, Rennie A, Bode WD, Vora R, Subramaniam S, Cooley B, Andrade-Gordon P, Antoniak S, Mackman N (2018) The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction. Thromb Res 167:128\u2013134","journal-title":"Thromb Res"},{"key":"1377_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jphs.2018.07.002","volume":"137","author":"H Imano","year":"2018","unstructured":"Imano H, Kato R, Tanikawa S, Yoshimura F, Nomura A, Ijiri Y, Yamaguchi T, Izumi Y, Yoshiyama M, Hayashi T (2018) Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia. J Pharmacol Sci 137:274\u2013282","journal-title":"J Pharmacol Sci"},{"key":"1377_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/europace\/eup328","volume":"12","author":"K Nishida","year":"2010","unstructured":"Nishida K, Michael G, Dobrev D, Nattel S (2010) Animal models for atrial fibrillation: clinical insights and scientific opportunities. Europace 12:160\u2013172","journal-title":"Europace"},{"key":"1377_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cardiores.2004.03.026","volume":"63","author":"N Hanna","year":"2004","unstructured":"Hanna N, Cardin S, Leung TK, Nattel S (2004) Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 63:236\u2013244","journal-title":"Cardiovasc Res"},{"key":"1377_CR18","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1538-7836.2008.03064.x","volume":"6","author":"T Furugohri","year":"2008","unstructured":"Furugohri T, Isobe K, Honda Y, Matsumoto C, Sugiyama N, Nagahara T, Morishima Y, Shibano T (2008) Du-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost 6:1542\u20131549","journal-title":"J Thromb Haemost"},{"key":"1377_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/01.RES.0000258428.09589.1a","volume":"100","author":"S Cardin","year":"2007","unstructured":"Cardin S, Libby E, Pelletier P, Bouter SL, Takeshita A, Meur NL, Leger J, Demolombe S, Ponton A, Glass L, Nattel S (2007) Contrasting gene expression profiles in two canine models of atrial fibrillation. Circ Res 100:425\u2013433","journal-title":"Circ Res"},{"key":"1377_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.yjmcc.2008.08.007","volume":"45","author":"S Cardin","year":"2008","unstructured":"Cardin S, Pelletier P, Libby E, Bouter SL, Xiao L, Kaab S, Demolombe S, Glass L, Nattel S (2008) Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure. J Mol Cell Cardiol 45:821\u2013831","journal-title":"J Mol Cell Cardiol"},{"key":"1377_CR21","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.106.624320","volume":"114","author":"KW Lee","year":"2006","unstructured":"Lee KW, Everett T, Rahmutula D, Guerra JM, Wilson ED, Ding C, Olgin JE (2006) Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation 114:1703\u20131712","journal-title":"Circulation"},{"key":"1377_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejphar.2013.09.006","volume":"718","author":"A Bukowska","year":"2013","unstructured":"Bukowska A, Zachrias I, Weinert S, Skopp K, Hartmann C, Huth C, Goette A (2013) Coagulation factor Xa induces an inflammatory signaling by activation of protease-activated receptors in human atrial tissue. Eur J Pharmacol 718:114\u2013123","journal-title":"Eur J Pharmacol"},{"key":"1377_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/0735-1097(89)90230-1","volume":"13","author":"SS Maze","year":"1989","unstructured":"Maze SS, Kotler MN, Parry WR (1989) Flow characteristics in the dilated left ventricular with thrombus: qualitative and quantitative Doppler analysis. J Am Coll Cardiol 13:873\u2013881","journal-title":"J Am Coll Cardiol"},{"key":"1377_CR24","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/0735-1097(95)00049-A","volume":"25","author":"K Yamamoto","year":"1995","unstructured":"Yamamoto K, Ikeda U, Furuhashi K, Irokawa M, Nakayama T, Shimada K (1995) The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 25:1634\u20131640","journal-title":"J Am Coll Cardiol"},{"key":"1377_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/000331979404500204","volume":"45","author":"CG Gustavsson","year":"1994","unstructured":"Gustavsson CG, Persson SU, Larsson H, Persson S (1994) Changed blood rheology in patients with idiopathic dilated cardiomyopathy. Angiology 45:107\u2013111","journal-title":"Angiology"},{"key":"1377_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1536\/ihj.15-112","volume":"56","author":"T Hashikata","year":"2015","unstructured":"Hashikata T, Tojo M, Namba S, Kitasato L, Kameda R, Murakami M, Niwano H, Shimohama T, Tojo T, Ako J (2015) Rivaroxaban inhibits fibrotic progression in vitro. Int Heart J 56:544\u2013550","journal-title":"Int Heart J"},{"key":"1377_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/sj.bjp.0707150","volume":"150","author":"E Ritchie","year":"2007","unstructured":"Ritchie E, Saka M, MacKenzie C, Drummond R, Wheeler-Jones C, Kanke T, Plevin R (2007) Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase \u03b2 in human endothelial cells. Br J Pharmacol 150:1044\u20131054","journal-title":"Br J Pharmacol"},{"key":"1377_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCRESAHA.108.175463","volume":"103","author":"XY Qi","year":"2008","unstructured":"Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chaetier D, Villeneuve LR, Brundel BJ, Dobrev D, Nattel S (2008) Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ Res 103:845\u2013854","journal-title":"Circ Res"},{"key":"1377_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1161\/01.RES.87.6.440","volume":"87","author":"S Nattel","year":"2000","unstructured":"Nattel S, Li D (2000) Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res 87:440\u2013447","journal-title":"Circ Res"},{"key":"1377_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","volume":"54","author":"M Allessie","year":"2002","unstructured":"Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230\u2013246","journal-title":"Cardiovasc Res"},{"key":"1377_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","volume":"100","author":"D Li","year":"1999","unstructured":"Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100:87\u201395","journal-title":"Circulation"},{"key":"1377_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/01.CIR.0000109501.47603.0C","volume":"109","author":"TJ Cha","year":"2004","unstructured":"Cha TJ, Ehrlich JR, Zhang L, Shi Y-F, Tardif J-C, Leung T-K, Nattel S (2004) Dissociation between ironic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 109:412\u2013418","journal-title":"Circulation"},{"key":"1377_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCEP.111.965178","volume":"5","author":"A Goette","year":"2012","unstructured":"Goette A, Schon N, Kirchhof P, Breithardt G, Fetsch T, Hausler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T (2012) Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Circ Arrythm Electrophysiol 5:43\u201351","journal-title":"Circ Arrythm Electrophysiol"},{"key":"1377_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1250","author":"K Rahimi","year":"2011","unstructured":"Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW (2011) Effect of statin on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomized controlled trials. BMJ. https:\/\/doi.org\/10.1136\/bmj.d1250","journal-title":"BMJ"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01377-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-019-01377-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-019-01377-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T13:39:21Z","timestamp":1694698761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-019-01377-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s00380-019-01377-2","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}